MOLECULAR IODINE COMPOSITION FOR HUMAN USE FOR THE PREVENTION AND TREATMENT OF PROSTATIC PATHOLOGIES

摘要

The invention relates to a pharmaceutical composition for preventing and treating prostatic pathologies in humans such as benign prostatic hyperplasia (BPH) or prostate cancer. The composition is characterised in that it contains between 3 and 10 mg of molecular iodine as the active substance, combined with pharmaceutically acceptable excipients and can be prepared in an oral form (tablets, solution or drops) and in a topical form (gel or delayed release patch). The composition also has a cardioprotector effect when used as an adjuvant with anti-cancer drugs such as anthracyclines.